The analgesic potential of intraventricular polymer-encapsulated adrenal chromaffin cells in a rodent model of chronic neuropathic pain

Experimental and Clinical Psychopharmacology

Volumn 8, Issue 4, 2000, Pages 524-538

  Lindner, Mark D ^a,b   Francis, Jonathan M ^a   Plone, Melissa A ^a   McDermott, Patricia E ^a   Frydel, Beata R ^a   Emerich, Dwaine F ^a   Saydoff, Joel A ^a  

^a CytoTherapeutics   (United States)

^b NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYMER;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN VENTRICLE; CELL TRANSPLANTATION; CHROMAFFIN CELL; CHRONIC PAIN; CONTROLLED STUDY; IMPLANTATION; MALE; NERVE LIGATION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; RAT; SCIATIC NERVE; SPINAL CORD;

EID: 0033645227     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.8.4.524     Document Type: Article

References (61)

1. Transplantation in humans of encapsulated xenogeneic cells without immunosuppression: A preliminary report
2. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
3. One-year chromaffin cell allograft survival in cancer patients with chronic pain: Morphological and functional evidence
4. Immunoisolated xenogeneic chromaffin cell therapy for chronic pain: Initial clinical experience
5. Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: Involvement of kappa-, but not delta-opioid receptors
6. Update on cellular transplantation into the CNS as a novel therapy for chronic pain
7. Intrathecal implants of bovine chromaffin cells alleviate mechanical allodynia in a rat model of neuropathic pain
8. Computational procedures for estimating magnitude of effect for some analysis of variance designs
9. Adrenal medullary implants reduce transsynaptic degeneration in the spinal cord of rats following chronic constriction nerve injury
10. Reduced pain-related behavior by adrenal medullary transplants in rats with experimental painful peripheral neuropathy
11. Alleviation of neuropathic pain symptoms by xenogeneic chromaffin cell grafts in the spinal subarachnoid space
12. Modulation of NMDA receptor expression in the rat spinal cord by peripheral nerve injury and adrenal medullary grafting
13. Loss of GABA-immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts
14. The cold plate as a test of nociceptive behaviors: Description and application to the study of chronic neuropathic and inflammatory pain models
15. Opioids in the brain: Supraspinal mechanisms in pain control
16. Descending noradrenergic influences on pain
17. Transplantation of human chromaffin cells for control of intractable cancer pain
18. Differential action of morphine and various opioid agonists on thermal allodynia and hyperalgesia in mononeuropathic rats
19. Therapeutic potential of a polymer-encapsulated L-DOPA and dopamine-producing cell line in rodent and primate models of Parkinson's disease
20. Intraventricular encapsulated calf adrenal chromaffin cells: Viable for at least 500 days in vivo without detectable adverse effects on behavioral/cognitive function or host immune sensitization in rats
21. Effects of intraventricular encapsulated hNGFsecreting fibroblasts in aged rats
22. Potentiation of the analgesic properties of fentanyl-like opioids with alpha(2)-adrenoceptor agonists in rats
23. Origin of afferent projections into bovine chromaffin cell implants in the rat periaqueductal gray determined by retrograde and anterograde tracing
24. Effect of amitriptyline on the analgesia induced by adrenal medullary tissue transplanted in the rat spinal subarachnoid space as measured by an experimental model of acute pain
25. Fine structural correlates of vascular permeability of chromaffin cell transplants in CNS pain modulatory regions
26. Morphological correlates of chromaffin cell transplants in CNS pain modulatory regions
27. The fine structure of chromaffin cell implants in the pain modulatory regions of the rat periaqueductal gray and spinal cord
28. Chromaffin cell transplants for alleviation of chronic pain
29. Chromaffin cell transplants in the CNS: Basic and clinical update
30. Neurochemical and phenotypic characteristics of isolated chromaffin cells as cellular implants for analgesia
31. Increased levels of Metenkephalin-like immunoreactivity in the spinal cord CSF of rats with adrenal medullary transplants
32. Adrenal medullary transplants increase spinal cord cerebrospinal fluid catecholamine levels and reduce pain sensitivity
33. Neuropeptide and catecholamine delivery to central nervous system by implanted chromaffin cells
34. Morphological and functional correlates of chromaffin cell transplants in CNS pain modulatory regions
35. Pain reduction by chromaffin cell grafts in the CNS
36. Pharmacologic consequences of the vascular permeability of chromaffin cell transplants in CNS pain modulatory regions
37. Host-graft relationships of isolated bovine chromaffin cells in rat periaqueductal grey
38. Adrenal medullary tissue transplants in the rat spinal cord reduce pain sensitivity
39. Alterations in nociception following adrenal medullary transplants into the rat periaqueductal gray
40. Fine structure of adrenal medullary grafts in the pain modulatory regions of the rat periaqueductal gray
41. Analgesia induced by isolated bovine chromaffin cells implanted in rat spinal cord
42. Prolonged analgesia by enkephalinase inhibition in rats with spinal cord adrenal medullary transplants
43. Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model
44. Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances
45. Alterations in rat spinal cord cGMP by peripheral nerve injury and adrenal medullary transplantation
46. Attenuation of NMDA-induced spinal hypersensitivity by adrenal medullary transplants
47. Attenuation of formalin pain responses in the rat by adrenal medullary transplants in the spinal subarachnoid space
48. Adrenal medullary transplants attenuate sensorimotor dysfunction in rats with peripheral neuropathy
49. The problems of delivering neuroactive molecules to the CNS
50. Supraspinal contributions to hyperalgesia
51. Optimization of adrenal medullary allograft conditions for pain alleviation
52. Attenuation of pain-related hyperventilation in adjuvant arthritis rats with adrenal medullary transplants in the spinal subarachnoid space
53. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats
54. MK-801, an NMDA receptor antagonist, in the rostroventromedial medulla attenuates development of neuropathic symptoms in the rat
55. Subarachnoid adrenal medullary transplants for terminal cancer pain: A report of preliminary studies
56. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing
57. Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, a-adrenergic agonists and baclofen
58. Spinal pharmacology of thermal hyperesthesia induced by incomplete ligation of sciatic nerve
59. Ethical guidelines for investigators of experimental pain in conscious animals